Sign in
4

Changes in Ownership

Acrivon Therapeutics, Inc. Filed Acc 0000905148-25-003121

President and CEO gave up 19,905 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Blume-Jensen Peter · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-08-21 Shares withheld for taxes : show line 1 in the form −19,905 $1.32 $26,275 2,126,440 D
Loading xslF345X05/form4.xml…